Editor's key points † Previous studies have suggested a link between deep anaesthesia and mortality. † The authors studied this association using data from two previous studies. † A multivariate analysis did not show an association between .5 min of EEG suppression and mortality. † EEG suppression and coincident hypotension were however strongly associated with mortality.
punctuated by bursts of activity, a pattern described as EEG burst suppression. 9 EEG burst suppression has also been observed in pathological states, including traumatic brain injury, coma, severe hypothermia, hypoxia, hypoglycaemia, or childhood encephalopathies. 10 -13 Computer models indicate that burst suppression results from depleted intracellular ATP and extracellular calcium stores and is associated with depressed neuronal metabolism. 14 15 As such, burst suppression could directly reflect important neurobiological processes. The potential clinical relevance of EEG suppression was made salient in a study in medical intensive care patients which found that burst suppression was independently associated with a doubling of mortality at 6 months. 16 In this respect, avoiding the potential harm of intraoperative EEG suppression by reducing anaesthetic agents might be worthy of further investigation. Analysis into postoperative outcomes after low intraoperative BIS values have prompted an ongoing debate about the potential of relatively excessive anaesthetic administration, within a clinically relevant range, to be directly injurious and to increase postoperative mortality. Many of these studies have been dispraised for incompletely capturing confounding factors. 17 -19 Preliminary research has shown that patients are more likely to exhibit EEG suppression during general anaesthesia with propofol when they were elderly, male, or had coronary artery disease. 20 The primary goal of this study was to investigate whether intraoperative EEG suppression is an independent predictor of 90 day postoperative mortality in patients at risk for intraoperative awareness who underwent general anaesthesia with volatile anaesthetics. A secondary goal was to explore risk factors for intraoperative EEG suppression.
Methods

Patient population
This study includes subjects from the B-Unaware (NCT00281489) and BAG-RECALL (NCT00682825) clinical trials, which were designed to test whether an anaesthetic protocol based on BIS guidance was superior to a protocol based on end-tidal anaesthetic concentration (ETAC) alerts in preventing intraoperative awareness. 21 In this substudy, we included patients whose surgeries lasted at least 30 min and whose intraoperative EEG suppression was recorded and available for at least half of the case's duration. Suppression ratio (SR) values were excluded from analysis if the BIS electrode's indicated signal quality index was ,50. SR was not a primary target in this study's parent trials and hence was not recorded electronically for many cases (Fig. 1) . We included intraoperative data from the most recent surgery if a patient had multiple operations in one or both studies. Our final sample included 2662 patients.
Ethics
Both parent trials (B-Unaware and BAG-RECALL) received regulatory approval from institutional review boards at all participating institutions, and both studies specified at registration that associations between anaesthetic depth and postoperative mortality would be explored in secondary studies (NCT00682825, NCT00281489).
Outcome measures and data collection
SR is a variable calculated by the BIS monitor w (Covidien, Boulder, CO, USA) as the per cent of the previous 63 s during which the EEG was suppressed. 24 BIS and SR values were recorded electronically using BIS Quatro w (Covidien) forehead electrodes and a BIS XP w (Covidien) processing module. For patients included in this substudy, ETAC and SR values were recorded using Trendface Solo software (ixellence, Wildau, Germany).
Data were processed using Matlab w 7.14 R2012a (The MathWorks Inc., Natick, MA, USA). ETAC and SR measurements were resampled to intervals of one measurement per minute by retaining the first value of every minute, and ETAC values were converted to MAC equivalents using the formulae provided by Nickalls. 23 Anaesthetic concentrations were considered missing when ETAC fell outside the range of 0.1 -4 MAC equivalents. To evaluate the relationship between EEG suppression and mortality, we estimated the total time during which a patient's EEG was suppressed by summing each case's fractional SR values and multiplying them by 100. Leslie and colleagues 7 analysed patients according to whether or not BIS was ,40 for at least 5 min. Based on this approach, we defined a 'suppressed group' of patients whose EEGs were suppressed for at least 5 cumulative (but not necessarily contiguous) minutes; the 'non-suppressed group' included the remaining patients. Perioperative data were retrieved from medical files. Postoperative mortality dates were ascertained from the US Social Security Death Index and by contacting patients and their families in Canada to establish vital status.
Statistics
Differences in patient characteristics and comorbidities between the suppressed and non-suppressed groups were evaluated with Student's t-test and x 2 test as appropriate. Normality of continuous variables was verified with one-sided Kolmogorov-Smirnov tests before parametric statistics were applied. We evaluated the unadjusted association between EEG suppression and postoperative mortality using a univariable logistic regression. To account for significant differences in baseline characteristics between the suppressed and nonsuppressed group, we propensity matched each suppressed case with up to two non-suppressed controls based on their patient characteristics and comorbid covariates (Table 1) . 25 We performed a 2:1 nearest neighbour matching with replacement to allow every suppressed case to be matched to at least one control, and a calliper allowed matches up to a distance of 0.2 standard deviations of the predicted propensity score. 26 27 To account for controls matched to multiple cases, we generated weights to deflate the sample to its original size. The paired t-tests and x 2 tests were used to evaluate differences before and after matching, and variance ratios and absolute values of the standardized differences in means were used to evaluate post-match balance between the two matched groups.
28
Survival information beyond the 90 day postoperative period was available for 2420 (90.9%) patients. To evaluate the potentially longer-term effects of EEG suppression, we used the Kaplan -Meier analyses to determine the association between EEG suppression and time to mortality up to 1 yr after surgery. A conditional multivariable logistic regression was performed using data from the matched patient cohort to evaluate the independent effect of EEG suppression on 90 day mortality. Covariates were defined a priori by clinical relevance or significance in prior research studies. They included age (continuous), gender, ASA physical status score (dichotomous, defined as IV vs I-III), number of comorbidities (continuous), planned heart surgery, history of congestive heart failure or malignancy (all dichotomous), duration of low mean arterial pressure (MAP) (,55 mm Hg), and an interaction term between low MAP and EEG suppression group. 8 All variables were force-entered into the model in a single step. Model goodness of fit was assessed with the log-likelihood ratio.
Finally, we constructed a non-linear mixed effects model using the complete, unmatched patient sample to evaluate the strength of association between several candidate risk factors and intraoperative burst suppression. Because most 
Results
This analysis included 2662 unique patients (Fig. 1 ) who provided 10 216 h of recorded intraoperative parameters. Most surgeries were performed by cardiothoracic (60.5%), general (14.8%), or urological (6.1%) services. Seven hundred and fiftysix (28.4%) patients experienced .5 cumulative minutes of suppressed EEG and comprised the suppressed group. The median duration of EEG suppression in the suppressed group was 15.3 min (range: 5.0-235.6 min), compared with 0.2 min (range: 0.0 -5.0 min) in the non-suppressed group. Patients in the suppressed group tended to be older, had higher ASA scores, and had a higher prevalence of many comorbidities, but a 46% reduced prevalence of malignancy compared with patients in the non-suppressed group (12.2% vs 22.4%, P,0.001; Table 1 ). Patients in the suppressed group were less likely to regularly use sedatives, including alcohol, benzodiazepines, or opioids.
Mortality analyses
The 90 day all-cause mortality rate in our study cohort was 3.9% (105 of 2662). Mortality at 90 days was 6.3% (48 of 756) in the suppressed group, 3.0% (57 of 1906) in the nonsuppressed group (P,0.001), and 5.5% (51 of 926) in the matched cohort (P¼0.456). Before adjusting for confounders, patients in the suppressed group had 2.19 (95% CI: 1.48 -3.26) times higher odds of dying up to 90 days after surgery than those in the non-suppressed group.
There were no significant differences in patient characteristics or prevalence of comorbidities between the two propensitymatched groups (Table 1) . No absolute value of the standardized mean difference for any variable exceeded 0.25, and no variance ratio was outside the range of 0.5-2. After matching and adjusting for confounding factors, patients who experienced EEG suppression had similar odds of dying by 90 days as their non-suppressed counterparts [odds ratio (OR)¼0.83, 95% confidence interval (CI)¼0.55-1.25, P¼0.375; Table 2 ]. However, patients in the suppressed group who also had low MAP had nearly three times higher odds of dying compared with their non-suppressed counterparts without low arterial pressure (OR¼2.96, 95% CI: 1.34-6.52, P¼0.007). Comparisons of the proportion of patients surviving up to 1 yr after surgery revealed that patients with EEG suppression had a shorter time-to-death than the non-suppressed group (log-rank x 2 ¼14.09, df¼1, P¼0.0002), but there was no significant difference between the patients with EEG suppression and their matched counterparts (log-rank x 2 ¼2.13, df¼1, P¼0.14; Fig. 2 ).
Predictors of burst suppression
After censoring unstable MAC values, 2356 h of data remained available for analysis in the mixed effects model (Table 3 ). In general, higher concentrations of volatile anaesthetics and higher doses of benzodiazepines or opioids were associated with increased burst suppression incidence and severity, and patients who received nitrous oxide had decreased incidence and severity of EEG suppression. Patients older than 60 yr had 5.31 times (OR¼5.31, 95% CI: 3.81-7.41, P,0.0001) higher odds of developing EEG suppression compared with their younger counterparts, and each additional comorbidity increased their odds by 43% (OR¼1.43, 95% CI: 1.29-1.70, P,0.0001). Chronic obstructive pulmonary disease was also associated with increased incidence of EEG suppression (OR¼1.65, 95% CI: 1.07-2.53, P¼0.023). Regular users of alcohol, benzodiazepines, and opioids had lower odds of developing EEG suppression (OR¼0.53, 95% CI: 0.38-0.75, P¼0.0003).
Discussion
The major reason motivating this study was an ongoing debate about the potential of relatively excessive anaesthetic administration, within a clinically relevant range, to be directly injurious and to increase postoperative mortality. This study found that when considered in the absence of other clinical factors, intraoperative EEG suppression is strongly associated with postoperative mortality. However, the significant bivariate association between EEG suppression and mortality was attenuated through matching and multivariate analysis. These results do not support the hypothesis that relatively excessive anaesthetic administration, as reflected by intraoperative EEG suppression, is an independent predictor of 90 day postoperative mortality. However, EEG suppression may contribute to postoperative mortality in conjunction with low MAP during the same general anaesthesia.
Unsurprisingly, EEG suppression was related to increasing anaesthetic administration. Interestingly, there was also an independent relationship between certain patient morbidities and EEG suppression. This suggests, as others have found, that intraoperative EEG suppression is a marker of patient frailty, albeit a weak marker. We chose to examine the link between EEG suppression and mortality, rather than between a particular processed EEG index and mortality, as most intraoperative EEG monitors record EEG suppression. We therefore felt that the results of this study would have relevance for any EEG-based intraoperative brain monitor. Although the BIS algorithm is proprietary, we do know that at lower BIS values, the index is inversely correlated with the extent of EEG suppression. 31 32 The results of this study are therefore consistent with the findings of several other observational studies that have not found an independent link between cumulative duration of low BIS values and postoperative mortality. 6 8 33 The strong univariate association between EEG suppression and mortality is striking and, if viewed uncritically, could lead to a possibly erroneous conclusion that intraoperative EEG suppression causes mortality. This emphasizes the importance of appropriate statistical adjusting techniques (e.g. propensity matching) and inclusion of known important confounders when assessing candidate associations between perioperative variables and postoperative outcomes in non-randomized studies. However, the propensity scoring techniques used here, while effective, may not have been fully inclusive of all relevant covariates. It is possible that a confounding variable may be responsible for the significance of the EEG suppression -low MAP interaction, as the presence of both conditions may be an indicator of 'sickness'. One limitation of this study is that there is no physiological justification for the 5 min suppression threshold used in the propensity match. However, using a historically precedented threshold improves comparison with previous research. 7 Additionally, although selected a priori, this threshold conveniently subdivided the subject pool without making any single group overly small. The result regarding nitrous oxide demonstrates that caution is warranted in interpreting SR as an accurate barometer of excessive anaesthetic depth. The addition of nitrous oxide is likely to deepen anaesthesia, but in this study, nitrous oxide was associated with a decrease in SR. An additional limitation of this study is that its observational methodology precluded us from accounting for all confounders, including temperature, which was not recorded in this study's parent trials. Even rigorous statistical approaches cannot ensure that the experimental and the control groups are equivalent apart from the exposure, which in this study was EEG suppression. Only a study that randomizes patients to EEG suppression (or its avoidance) as a therapeutic intervention can provide a more compelling answer to the hypothesis that intraoperative EEG suppression increases postoperative mortality. After the matching, the lack of an association between EEG suppression and mortality could be a false-negative finding. However, the CI for the propensity-matched OR suggests that even if there is a causal link between EEG suppression and mortality, it is likely to be a weak association. Although the findings of this study are conflicting in relation to the link between intraoperative EEG suppression and mortality reported by former trials, there are other important outcomes that this study did not evaluate. 5 -7 These include longer-term postoperative mortality, quality of postoperative recovery, postoperative morbidity, and postoperative cognition. If intraoperative EEG suppression had a direct association with postoperative mortality, one would expect the largest mortality differences to occur rapidly after surgery. It is possible that 90 days are too long a period after surgery to find a significant difference. However, in this sample, the 90 day mortality rate was necessary to ensure enough events to perform a multivariate analysis without over-fitting. Future studies may consider investigating the association between EEG suppression endpoints such as delirium or postoperative cognitive changes to further explore any long-term effects of EEG suppression.
The findings of this study do not support the contention that volatile anaesthetic dose should be limited within a clinically relevant range in order to avoid intraoperative EEG suppression to decrease postoperative mortality. There is no compelling reason to desist from the practice of inducing EEG suppression when it is thought to be clinically indicated (e.g. during certain brain surgeries). However, even if EEG suppression is not associated with direct harm, for the most part, it is likely to reflect unnecessarily deep anaesthesia and should be further investigated with a randomized controlled trial.
